Brief: Hyloris Launches Non-Opioid Pain Treatment Maxigesic IV In Germany, Austria
July 8 (Reuters) - HYLORIS PHARMACEUTICALS SA HYL.BR :
* ANNOUNCES LAUNCH OF MAXIGESIC IV, A NOVEL NON-OPIOID PAIN
TREATMENT, IN KEY EUROPEAN MARKETS
* MAXIGESIC IV IS NOW AVAILABLE IN GERMANY, LARGEST EUROPEAN
PHARMACEUTICAL MARKET, AND AUSTRIA
Source text for Eikon: ID:nGNE5cvjpd
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million